Table 1

Characteristics of study populations by site

CharacteristicSeason time pointThe GambiaKenyaP
Number  603 245 — 
Median age, mo (IQR)  46.8 (35.6, 59.4) 48.7 (25.7, 67.8) .78 
Median BMI (IQR)  14.5 (13.8, 15.4) 15.3 (14.5, 16.2) <.0005 
Male gender, no.  318 (52.7%) 136 (55.5%) .47 
Minority ethnic group,* no.  61 (10.1%) 38 (15.5%) — 
HbAS, no.  78 (13.4%) 29 (11.8%) .54 
G6PDd A- type, no.  23 (4.9%) 72 (34.4%) <.0005 
Hepcidin, ng/mL Start 11.2 (9.9, 12.7) 3.8 (3.1, 4.7) <.0005 
End 4.2 (3.6, 4.8) 1.3 (1.0, 1.7) <.0005 
ACT, g/L or CRP, mg/L Start 0.45 (0.44, 0.46) 0.78 (0.64, 0.95) — 
End 0.39 (0.39, 0.40) 0.87 (0.73, 1.05) — 
Ferritin, µg/L Start 25.5 (23.7, 27.4) 18.4 (16.2, 20.9) <.0005 
End 21.1 (19.5, 22.8) 13.6 (12.3, 15.2) <.0005 
sTfR, mg/L Start 3.4 (3.3, 3.5) 3.7 (3.5, 3.9) .002 
End 4.1 (4.0, 4.3) 3.6 (3.4, 3.8) <.0005 
Hb concentration, g/dL Start 10.6 (10.5, 10.7) n/a — 
End 9.9 (9.8, 10.1) 10.3 (10.0, 10.6) .13 
MCV, fL Start 75.4 (74.6, 76.2) n/a — 
End 74.7 (73.9, 75.5) 71.6 (69.8, 73.5) <.0005 
ID, no. (%) Start 112/601 (18.6%) 91/238 (38.2%) <.0005 
End 176/597 (29.5%) 114/245 (46.5%)§ <.0005 
IDA, no. (%) Start 83/595 (14.0%) n/a — 
End 150/595 (25.2%) 45/82 (54.9%) <.0005 
P. falciparum parasitemia, no. (%) Start 62/601 (10.3%) 41/243 (16.9%) .04 
End 156/602 (25.9%) 20/242 (8.3%) <.0005 
CharacteristicSeason time pointThe GambiaKenyaP
Number  603 245 — 
Median age, mo (IQR)  46.8 (35.6, 59.4) 48.7 (25.7, 67.8) .78 
Median BMI (IQR)  14.5 (13.8, 15.4) 15.3 (14.5, 16.2) <.0005 
Male gender, no.  318 (52.7%) 136 (55.5%) .47 
Minority ethnic group,* no.  61 (10.1%) 38 (15.5%) — 
HbAS, no.  78 (13.4%) 29 (11.8%) .54 
G6PDd A- type, no.  23 (4.9%) 72 (34.4%) <.0005 
Hepcidin, ng/mL Start 11.2 (9.9, 12.7) 3.8 (3.1, 4.7) <.0005 
End 4.2 (3.6, 4.8) 1.3 (1.0, 1.7) <.0005 
ACT, g/L or CRP, mg/L Start 0.45 (0.44, 0.46) 0.78 (0.64, 0.95) — 
End 0.39 (0.39, 0.40) 0.87 (0.73, 1.05) — 
Ferritin, µg/L Start 25.5 (23.7, 27.4) 18.4 (16.2, 20.9) <.0005 
End 21.1 (19.5, 22.8) 13.6 (12.3, 15.2) <.0005 
sTfR, mg/L Start 3.4 (3.3, 3.5) 3.7 (3.5, 3.9) .002 
End 4.1 (4.0, 4.3) 3.6 (3.4, 3.8) <.0005 
Hb concentration, g/dL Start 10.6 (10.5, 10.7) n/a — 
End 9.9 (9.8, 10.1) 10.3 (10.0, 10.6) .13 
MCV, fL Start 75.4 (74.6, 76.2) n/a — 
End 74.7 (73.9, 75.5) 71.6 (69.8, 73.5) <.0005 
ID, no. (%) Start 112/601 (18.6%) 91/238 (38.2%) <.0005 
End 176/597 (29.5%) 114/245 (46.5%)§ <.0005 
IDA, no. (%) Start 83/595 (14.0%) n/a — 
End 150/595 (25.2%) 45/82 (54.9%) <.0005 
P. falciparum parasitemia, no. (%) Start 62/601 (10.3%) 41/243 (16.9%) .04 
End 156/602 (25.9%) 20/242 (8.3%) <.0005 

All subjects had hepcidin measurements at 2 time points with no missing data. Other measurements may have been missing data from one or other time point. Only 82 Kenyan children had complete blood count data. Geometric mean values are presented for continuous variables, and categorical variables are represented by proportions (%). All analyses, except for that of age, were adjusted for age. ID was defined as ferritin <12 µg/L or ferritin <30 µg/L with inflammation (ACT >0.6 g/L or CRP >10 mg/L). IDA was defined as ID with Hb <11 g/dL if aged 6 mo to 4 y or Hb <11.5 g/dL if aged 5-12 y.

n/a, not available.

*

Ethnic groups in the Gambia were Mandinka and Fulani (minority group) and in Kenya were Giriama and Chonyi (minority group).

G6PDd A- heterozygotes and homozygotes combined.

P < .0005 for difference between start and end of season.

§

P = .007 for difference between start and end of season.

Close Modal

or Create an Account

Close Modal
Close Modal